Loading
Latest filing published 04 Sept 2026 for Actinium Pharmaceuticals, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Ajit Shetty is a declared insider at 2 companies (board member); the most frequent names are Agile Therapeutics Inc and Actinium Pharmaceuticals, Inc. Over a trading history stretching from 12 June 2017 to 2 September 2026, the count stands at 7 filings.
Every open-market trade on record is a purchase: 1 purchase worth €7,992, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 4 share grants and 2 option exercises.
On 4 September 2026 came the latest disclosure, a share grant in Actinium Pharmaceuticals, Inc. The most recent open-market purchase was published on 1 March 2018, 3,156 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations